Sign In
Register

Partnerships

Request your invite

Call to action
Your text goes here. Insert your content, thoughts, or information in this space.
Button

Back to speakers

Amir
Emadzadeh
Director, Software Engineering
Genentech
Amir Emadzadeh is a distinguished technology leader and innovator in the life sciences and autonomous systems industries. Currently serving as Director, Software Engineering at Genentech (Roche), he leads transformative initiatives in clinical trial automation and AI-driven healthcare solutions. His groundbreaking work includes developing patent-pending platforms that have significantly accelerated clinical data workflows and enhanced trial efficiency. Prior to Genentech, Amir held leadership positions at Gilead Sciences, Waymo, and Nvidia, where he pioneered advances in autonomous vehicle technology and medical image analysis. His expertise spans machine learning, signal processing, & algorithm development, with particular focus on healthcare applications & autonomous systems. Amir holds a Ph.D. in Electrical Engineering from UCLA, where his research on spacecraft navigation using X-ray pulsars led to a book published by Springer. He has been granted numerous patents and published extensively in prestigious journals. Currently serving as an adjunct professor at California Science and Technology University, Amir frequently speaks at major industry conferences on AI and clinical trial innovation. His work consistently demonstrates a commitment to pushing technical boundaries while maintaining practical applicability, particularly in healthcare & autonomous systems. Amir is recognized for his ability to lead diverse teams & drive innovation in complex technical environments.
29 April 2025 15:20 - 15:40
Panel discussion: Highly regulated environments - optimizing generative AI systems & strategy in compliance-critical industries
Regulated industries like finance and healthcare grapple with a unique set of challenges when implementing new technologies like generative AI. Stringent regulations and the risk of substantial penalties often lead to risk aversion, while the demand for high data quality is paramount. This interactive session brings together leaders from finance and healthcare to discuss the specific challenges they face such as regulatory hurdles, ensuring data privacy and security, and building trust with stakeholders while embracing the transformative potential of this technology.